Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 21;12(5):446.
doi: 10.3390/membranes12050446.

All-Solid-State Potentiometric Platforms Modified with a Multi-Walled Carbon Nanotubes for Fluoxetine Determination

Affiliations

All-Solid-State Potentiometric Platforms Modified with a Multi-Walled Carbon Nanotubes for Fluoxetine Determination

Hisham S M Abd-Rabboh et al. Membranes (Basel). .

Abstract

Novel cost-effective screen-printed potentiometric platforms for simple, fast, and accurate assessment of Fluoxetine (FLX) were designed and characterized. The potentiometric platforms integrate both the FLX sensor and the reference Ag/AgCl electrode. The sensors were based on the use of 4'-nitrobenzo-15-crown-5 (ionophore I), dibenzo-18-crown-6 (ionophore II), and 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD) (ionophore III) as neutral carriers within a plasticized PVC matrix. Multiwalled carbon nanotubes (MWCNTs) were used as a lipophilic ion-to-electron transducing material and sodium tetrakis [3,5-bis(trifluoromethyl)phenyl] borate (NaTFPB) was used as an anionic excluder. The presented platforms revealed near-Nernstian potentiometric response with slopes of 56.2 ± 0.8, 56.3 ± 1.7 and 64.4 ± 0.2 mV/decade and detection limits of 5.2 × 10-6, 4.7 × 10-6 and 2.0 × 10-7 M in 10 mM Tris buffer solution, pH 7 for sensors based on ionophore I, II, and III, respectively. All measurements were carried out in 10 mM tris buffer solution at pH 7.0. The interfacial capacitance before and after insertion of the MWCNTs layer was evaluated for the presented sensors using the reverse-current chronopotentiometry. The sensors were introduced for successful determination of FLX drug in different pharmaceutical dosage forms. The results were compared with those obtained by the standard HPLC method. Recovery values were calculated after spiking fixed concentrations of FLX in different serum samples. The presented platforms can be potentially manufacturable at large scales and provide a portable, rapid, disposable, and cost-effective analytical tool for measuring FLX.

Keywords: fluoxetine; multi-walled carbon nanotubes (MWCNTs); nanomaterials-based sensors; potentiometric sensors; screen printed.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest. All authors have approved the manuscript and agree with the submission to your esteemed journal.

Figures

Figure 1
Figure 1
Time-trace versus FLX concentration for sensors based on (A) ionophore I (B) ionophore II; (C) ionophore III; using o-NPOE, DOP and DBS as membrane solvent mediators. (Inset: calibration plot).
Figure 1
Figure 1
Time-trace versus FLX concentration for sensors based on (A) ionophore I (B) ionophore II; (C) ionophore III; using o-NPOE, DOP and DBS as membrane solvent mediators. (Inset: calibration plot).
Figure 2
Figure 2
pH-potential profiles for FLX membrane sensors plasticized in o, NPOE (A) ionophore I; (B) ionophore II and (C) ionophore III.
Figure 2
Figure 2
pH-potential profiles for FLX membrane sensors plasticized in o, NPOE (A) ionophore I; (B) ionophore II and (C) ionophore III.
Figure 3
Figure 3
Day-to-day performance characteristics of ionophore III based sensor.
Figure 4
Figure 4
Water layer tests for (A) non-modified, (B) and modified FLX sensors based on ionophores I, II, and III.
Figure 5
Figure 5
Current reversal chronopotentiometry for (a) non-modified and (b) modified FLX-ISEs based on ionophores I, II, and III.

References

    1. Visentin A.P.V., Colombo R., Scotton E., Fracasso D.S., da Rosa A.R., Branco C.S., Salvador M. Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges. Oxid. Med. Cell. Longev. 2020;2020:2972968. doi: 10.1155/2020/2972968. - DOI - PMC - PubMed
    1. Severe J., Greden J.F., Reddy P. Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe? Focus. 2020;18:120–128. doi: 10.1176/appi.focus.20200008. - DOI - PMC - PubMed
    1. Latha M.S., Sowjanya B., Abbulu K. Analytical method development for the simultaneous estimation of olanzapine and fluoxetine by RP-HPLC method. Int. J. Bio-Pharm. Res. 2019;8:2769–2774.
    1. Creeley C.E., Denton L.K. Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes. Brain Sci. 2019;9:235. doi: 10.3390/brainsci9090235. - DOI - PMC - PubMed
    1. Marazziti D., Avella M.T., Basile L., Mucci F., Dell’Osso L. Pharmacokinetics of serotonergic drugs: Focus on OCD. Expert Opin. Drug Metab. Toxicol. 2019;15:261–273. doi: 10.1080/17425255.2019.1584611. - DOI - PubMed